WE ARE INVESTIGATING THE FOLLOWING CLAIMS
McCallister Law Group, LLC is investigating claims on behalf of UberX drivers who may be considered as employees rather than as independent contractors under Illinois State Law. Classification as an employee may entitle UberX drivers to reimbursement for costs and other employment benefits incurred while transporting UberX customers to various destinations. Uber has maintained that under its business model, UberX drivers are “independent contractors” and not employees and, thus, expenses including gas and various taxes and workers’ compensation costs, must be borne by the driver. If you are now, or have been in the past, an UberX driver in Illinois and are interested in pursuing such a claim, you may contact our office and complete a free confidential online questionnaire so that you may explore your legal options and protect your legal rights.
McCallister Law Group, LLC is currently investigating and pursuing claims involving talcum powder which has been used for years by women who have applied talc-based powders either directly or indirectly to their private parts exposing their reproductive tracts to talcum powder. It has been shown that such women are at increased risk of developing ovarian or fallopian tube cancers and that Johnson & Johnson has failed to warn that such an exposure creates an increased risk for developing these types of cancers. As a result, efforts to enhance the warning label with regard to the increased risk associated with talcum powder and development of these cancers are underway.
The following companies market talcum powder, and our firm can investigate your potential claim to determine if use of these brands result in diagnosed ovarian or fallopian tube cancers:
- Johnson & Johnson
- Gold Bond Medicated Powder
- Clubman Pinaud Talc
- Shower to Shower
- Nivea Pure Talc Baby Powder.
If you believe you have a claim, you may contact our firm to learn more about your legal options and to protect your rights. We encourage you to contact us to discuss your possible claim and learn more about your rights after using talcum powder.
McCallister Law Group, LLC is currently investigating false advertising and other claims against Ashley Furniture who sells “DuraBlend” furniture without disclosing that it is not made of actual leather. This investigation relates to claims that DuraBlend (blended-leather upholstery) does not withstand ordinary wear and tear, but instead easily peels revealing a rough, off-white layer underneath. As a result, consumers have lost the benefit of their investment in this line of furniture and may have been victims of other deceptive acts and practices under the Illinois Deceptive Practices Act. If you have purchased DuraBlend upholstered furniture from Ashley Furniture, you may contact our firm to explore your legal options and to protect your legal rights.
Onglyza and Kombiglyze XR are oral medications used to lower blood sugar levels in patients with Type 2 diabetes. Both drugs are known by the generic name saxagliptin and are classified as dipeptidyl peptidase-4 (DPP-4) inhibitors. The FDA first approved Onglyza in July 2008 and later approved Kombiglyze XR in November 2010. In February 2014, the FDA released a drug safety communication regarding Onglyza and Kombiglyze Xr side effects. The communication was issued following a New England Journal of Medicine study stating that the rate of hospitalization due to heart failure was increased in patients who were on Onglyza and Kombiglyze XR. In April 2015, the FDA’s Endocrinology and Metabolic Drugs Advisory Committee recommended adding a label to both drugs in order to warn consumers of increased cardiovascular risk. The increased cardiovascular risk takes the form of heart failure, congestive heart failure, cardiac arrest and death. If you or a loved one has taken one or both of these drugs, then you may contact our firm to explore your legal options in order to protect your rights.
McCallister Law Group, LLC is investigating claims involving coffee roaster workers who may be at an increased risk of suffering permanent respiratory disease, bronchiolitis obliterans, as a result of their exposure to diacetyl which is a flavoring agent involved in the roasting of coffee as well as other food products. The Centers for Disease Control and Prevention (“NIOSH”) has for years investigated flavorings-related lung disease as a result of workers being exposed to diacetyl. Regrettably, one form of severe, non-reversible lung disease that involves the scarring of the very small airways called bronchioles and in patchy distributions throughout the lung resulting in symptoms of cough, shortness of breath on exertion and/or wheeze have been found in flavoring manufacturing workers. As a result, NIOSH is working with a number of coffee processing facilities through its health hazard evaluation program in an attempt to minimize the risk to workers at coffee processing facilities due to exposure to diacetyl.
If you or a loved one works in a work environment where flavoring agents such as diacetyl are used, you may contact our office to explore your legal options and to protect your rights.
McCallister Law Group, LLC is investigating the hidden dangers of push-button start ignitions when vehicles are inadvertently left running. This has lead to carbon monoxide poisoning.
In cars that have keyless, push-button ignitions, an electric key fob is recognized by the car to authorize driving and the use of power accessories. That fob can remain in a driver’s pocket or purse, as the ignition switch is simply a button on the dash of the vehicle.
Dangers arise when a driver inadvertently leaves a car running when exiting the vehicle. Even when the fob is taken with the driver, a car engine can continue to idle. If the car is parked in a closed garage attached to a house, especially a basement-level garage, carbon monoxide fumes from the idling engine may seep into the living area creating a potentially lethal threat to anyone in the house. This increased danger is even more prevalent in keyless-ignition hybrid and plug-in hybrid vehicles because they are virtually silent when in the electric mode. A failure to actually turn the car off may result in the engine restarting itself resulting in an idling engine which can exhaust carbon monoxide into a living area.
The National Highway Traffic Safety Administration (NITSA) has been aware of this issue for some time. News reports have linked more than a dozen carbon monoxide deaths to keyless ignitions. While some brands of vehicles have audible alerts where the engine has not been turned off and the engine remains idling, other brands do not have an audible warning.
If you or a loved one has been the victim of carbon monoxide poisoning from a keyless push-button start ignition vehicle, you may contact our firm to explore your legal options and to protect your legal rights.
McCallister Law Group, LLC is investigating claims involving Olympus TJF-Q180V duodenoscope which due to a redesign, is more difficult to disinfect before use putting surgery patients at an increased risk of infection. Investigations have shown that Olympus did not gain clearance from the Food and Drug Administration (“FDA”) before putting the scope on the market in 2010. As a result, individuals have died and 200 or more infections have been linked to antibiotic resistant superbugs which were associated with the use of the Olympus duodenoscope.
In January 2016, Olympus issued a recall for thousands of these scopes. Olympus and other duodenoscope makers have failed to prove the scopes could be adequately cleaned even when following their own instructions. The FDA announced additional techniques to be used in cleaning these devices even though these techniques might not be realistic for some hospitals to be able to guarantee the devices are safe. In addition to Illinois, other states, including Pennsylvania, California, Florida and Washington, have reported super bug outbreaks have occurred as a result of the use of these endoscopes which are inserted into either a person’s mouth or rectum depending upon the diagnostic test being performed.
If you or a loved one has been diagnosed with carbapenem-resistant Enterobacteriaceae (“CRE”) from the use of a diagnostic procedure utilizing an endoscope, then you may want to contact our firm to explore your legal options and protect your legal rights.
McCallister Law Group, LLC is investigating cases involving women who have been diagnosed with cancer after undergoing a hysterectomy or a myomectomy where a laproscopic power morcellator (“LPM”) was used. The FDA issued a safety communication on April 17, 2014, discouraging the use of laproscopic power morcellators for the removal of the uterus and uterine fibroids, citing a risk for the spread of unsuspected cancerous tissue. The manufacturer of the power morcellators, Ethicon, a Johnson & Johnson company, immediately suspended the sales of laproscopic power morcellators around the world.
It has been estimated that around 500,000 women undergo hysterectomies on an annual basis. Of this total, approximately 11% of hysterectomies have been performed using a power morcellator which means approximately 50,000 women undergo laproscopic morcellation hysterectomies annually.
If you or a loved have undergone a hysterectomy or myomectomy in which a power morcellator has been used and you have contracted uterine cancer, you may want to contact our firm to investigate your legal options and protect your legal rights.
McCallister Law Group, LLC is investigating infections which may be associated with the use of Bair Hugger Forced-Air Warming Blankets designed to keep patients warm during orthopedic surgery. Evidence has shown that patients undergoing hip or knee replacement surgeries have developed deep joint infections after surgery where Bair Hugger Forced-Air Warming Blankets were used during the procedure.
If you or a loved one has suffered a deep joint infection following knee or hip replacement surgery where a forced-air warming blanket was utilized during the procedure, you may want to contact our firm to explore your legal options and protect your rights.
Humira is a popular drug used to treat and combat Rheumatoid Arthritis and other autoimmune diseases, including juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, Crohn’s disease, and ulcerative colitis. Despite its success in combating many diseases, it is known to cause severe and sometimes even fatal side effects.
Humira, also known as the generic drug Adalimumab, is an anti-Tumor Necrosis Factor (TNF) pharmaceutical, sometimes called a TNF blocker, which was first approved by the FDA in December 2002 and launched by Abbott Laboratories in 2003. TNF, a small protein called a cytokine, plays an important role in regulating immune responses in order to defend the body against infectious diseases and foreign materials. Individuals who suffer from autoimmune disorders produce very high levels of TNF, causing the immune system to mistakenly attack healthy tissue. This triggers pain, inflammation, swelling, and cell and joint damage.
TNF inhibitor drugs such as Humira are used to alleviate pain for those who suffer from autoimmune diseases. Because it blocks the extra amounts of TNF, Humira might help relieve the symptoms of the underlying disease.
While Humira may provide relief for people suffering from certain autoimmune disorders, it also simultaneously compromises the immune system and its ability to function correctly because it can lower blood cells that help the body fight infection. As a result, Humira has been associated with serious, harmful, and sometimes even deadly side effects.
Medical studies have shown that patients taking Humira face a high risk of developing several kinds of cancer and severe infections within three to 12 months from the first dose. Some patients using Humira have developed a rare, sometimes fatal, fast-growing type of lymphoma. Humira also has been connected to serious infections such as tuberculosis, pathogenic viruses, bacterial sepsis, bacterial pathogens Legionella and Lysteria, and often fatal fungal infections including histoplasmosis, blastomycosis, and coccidioidomycosis.
When it first came on the market after FDA approval in 2002, Humira’s label targeted physicians marketing Humira as a wonder drug with minor side effects. Abbott provided very few warnings beyond a risk of tuberculosis. It failed to adequately warn physicians and patients about the serious and sometimes deadly side effects related to Humira and known to Abbott and instead focused only on the positive affects of the drug. Since the initial 2002 approval, the label has quadrupled in length because the FDA has mandated approximately 20 changes along with numerous additions to warnings and risks. In 2009, the FDA ordered the expansion of the Black Box warning. Humira’s label now mentions the increased risk of lymphoma and other malignancies in children and adolescent patients, as well as serious infections and nervous system disorders including multiple sclerosis, heart failure, and many problems with drug interactions.
Thank you for contacting McCallister Law Group about your potential legal claim. Please fill out the following questionnaire as thoroughly as possible.